Is ServiceNow Stock a Buy After Shares Sink?

ServiceNow reported Q1 revenue of $3.77 billion, up 22% year over year, and adjusted EPS of $0.97, both slightly ahead of consensus. Subscription revenue rose 22% to $3.67 billion, while RPO growth decelerated to 23.5% from 26.5% in Q4 and cRPO growth slowed to 21% from 25%, which pressured the stock despite raised full-year subscription revenue guidance to $15.735 billion-$15.775 billion. The article argues the shares may be undervalued at 5.5x forward sales and 20x forward earnings, especially given AI-related opportunities.

Analysis

The market is treating slowing backlog conversion as a signal that the AI monetization story is slipping, but the bigger issue is valuation discipline: high-multiple SaaS names are no longer being paid for “quality” alone, only for acceleration. That creates a negative reflexive loop where even decent prints get sold if forward indicators merely normalize, and it likely keeps pressure on the entire top tier of enterprise software until at least one or two quarters of clear re-acceleration show up.

The more interesting second-order effect is that ServiceNow’s AI push may actually be a competitive moat enhancer rather than a near-term revenue accelerator. If AI Control Tower becomes the orchestration layer for enterprise agent workflows, it raises switching costs across workflow, ITSM, and security use cases, but that benefit will likely show up first in deal durability and expansion rates, not headline growth. In other words, the market is discounting a longer payoff profile because it wants an immediate monetization inflection that may not be structurally available for 2-4 quarters.

The contrarian case is that the selloff may be overdone relative to fundamentals: a high-margin business compounding near 20% with a forward P/S around mid-single digits and forward earnings around 20x is not priced like a durable platform leader. The main risk is not a collapse in demand but multiple compression if cRPO continues to decelerate into the next print; that would likely keep the stock range-bound to lower for weeks, even if execution remains solid. Conversely, any sign that AI-related modules are translating into faster expansion or better win rates could trigger a sharp re-rating because positioning is now meaningfully more defensive than it was a quarter ago.

Key Decisions for Investors

• Go long NOW on weakness with a 3-6 month horizon; target a re-rating back toward premium SaaS multiples if cRPO stabilizes, with downside limited by strong margin structure but near-term multiple risk if growth slips again.
• Structure a call spread in NOW rather than outright equity for the next 2 quarters; this captures upside from an AI-driven sentiment reversal while capping premium outlay if the stock stays range-bound.
• Pair long NOW / short a higher-beta, lower-quality SaaS peer basket over the next 1-2 quarters; the market is rewarding durable cash-flow franchises over weaker growth names, and NOW should defend better if software multiples stay compressed.
• Do not chase the stock before the next cRPO print; wait for evidence that the deceleration is a one-quarter digestion issue rather than a trend, because the stock likely remains headline-sensitive until then.
• Use a stop-loss discipline around any long NOW position if the next guidance update implies another cRPO step-down; that would convert the thesis from temporary re-rating dislocation into a genuine growth-regime change.